BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $138 at Jefferies
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $58.99 --0%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 23 | New: 29
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 23 | New: 29
Join SI Premium – FREE
Jefferies analyst Eun Yang raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $138.00 (from $132.00) while maintaining a Buy rating.
You May Also Be Interested In
- SharkNinja (SN) PT Raised to $175 at Guggenheim
- IDFC First Bank Ltd (IDFCFB:IN) PT Raised to INR85 at BofA Securities
- Aecon Group (ARE:CN) (AEGXF) PT Raised to Cdn$61 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
